Difficulty: Medium
Average Score: 88%
Practice
Radioiodines (I131 and I132) is suitable for:
Correct answer
A
Rationale
In nursing pharmacology, understanding the appropriate use of radioiodines like I131 and I132 is crucial for safe and effective patient care. The correct answer, option A, is elderly patients (over 45 years).
Radioiodines are used in the treatment of thyroid conditions such as hyperthyroidism or thyroid cancer. Elderly patients often have a higher incidence of thyroid disorders due to age-related changes in the endocrine system. Additionally, older patients may be less likely to undergo surgical interventions for thyroid conditions, making radioiodine therapy a suitable option.
Option B, pregnant women, is incorrect because radioiodines are contraindicated during pregnancy due to potential harm to the developing fetus. Radioiodines can cross the placenta and affect fetal thyroid function, leading to adverse outcomes.
Option C, nursing mothers, is also incorrect because radioiodines can be excreted in breast milk, potentially exposing the infant to radiation. Therefore, it is not recommended for use in nursing mothers.
Option D, younger patients, is incorrect because while radioiodine therapy can be used in younger patients, it is typically reserved for cases where other treatments have been ineffective or are contraindicated. Younger patients may have a longer lifespan ahead of them, increasing the risk of long-term radiation-related side effects.
Educationally, this question highlights the importance of considering lifespan considerations when prescribing medications, especially in vulnerable populations like the elderly, pregnant women, and nursing mothers. It also emphasizes the need for nurses to have a solid understanding of pharmacological principles to ensure safe medication administration and patient education.
Radioiodines are used in the treatment of thyroid conditions such as hyperthyroidism or thyroid cancer. Elderly patients often have a higher incidence of thyroid disorders due to age-related changes in the endocrine system. Additionally, older patients may be less likely to undergo surgical interventions for thyroid conditions, making radioiodine therapy a suitable option.
Option B, pregnant women, is incorrect because radioiodines are contraindicated during pregnancy due to potential harm to the developing fetus. Radioiodines can cross the placenta and affect fetal thyroid function, leading to adverse outcomes.
Option C, nursing mothers, is also incorrect because radioiodines can be excreted in breast milk, potentially exposing the infant to radiation. Therefore, it is not recommended for use in nursing mothers.
Option D, younger patients, is incorrect because while radioiodine therapy can be used in younger patients, it is typically reserved for cases where other treatments have been ineffective or are contraindicated. Younger patients may have a longer lifespan ahead of them, increasing the risk of long-term radiation-related side effects.
Educationally, this question highlights the importance of considering lifespan considerations when prescribing medications, especially in vulnerable populations like the elderly, pregnant women, and nursing mothers. It also emphasizes the need for nurses to have a solid understanding of pharmacological principles to ensure safe medication administration and patient education.